Elanco proposes divestments of some animal health products in Bayer acquisition

The ACCC is seeking views on a divestment undertaking offered by Elanco relating to its proposed acquisition of Bayer Aktiengesellschaft’s animal health business.

See ACCC media release.

See merger register.